Trial record 1 of 1 for:    nct01442194
Previous Study | Return to List | Next Study

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies (PASSAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01442194
Recruitment Status : Recruiting
First Posted : September 28, 2011
Last Update Posted : August 14, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Primary Completion Date : No date given
  Estimated Study Completion Date : December 26, 2022